Implementation of Motivational Interviewing in a diabetes care management initiative in The Netherlands

Patient Education and Counseling
Yvonne J L van Eijk-HustingsHubertus J M Vrijhoef

Abstract

Motivational Interviewing (MI) is a counseling approach to support behavioural change. The objective of the present study was to examine the uptake of MI in daily practice by health care professionals in a care management initiative for patients with diabetes in the region of Maastricht, the Netherlands. MI was implemented by means of a training. Directly and six months after the training, the application of MI was measured objectively (MITI) and subjectively (questionnaire). In focus interviews, MI-trained professionals (n=10) and MI untrained professionals (n=10) were asked about facilitators and barriers for implementation. Additionally, data on patient characteristics (n=141) were collected. Spirit of MI was present among professionals directly after the training and increased during follow-up. Mostly uncomplicated techniques were applied. Professionals stated the need for training and practice to be able to apply more complicated techniques. The applicability of MI in daily practice was found feasible, with various degrees of uptake. Relevant conditions to further improve the implementation of MI in daily practice were identified. In daily practice, a phased training in MI is recommended, with sufficient time and support b...Continue Reading

References

Jul 29, 1995·BMJ : British Medical Journal·J Kitzinger
Jun 6, 2000·Patient Education and Counseling·Y DohertyJ Simpson
Oct 17, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Jul 24, 2003·Archives of Disease in Childhood·S ChannonJ W Gregory
Aug 20, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·R M VinerS Hey
May 14, 2004·Patient Education and Counseling·Eileen BrittNeville M Blampied
Dec 23, 2004·Journal of Consulting and Clinical Psychology·William R MillerMatthew Pirritano
Feb 23, 2005·Journal of Substance Abuse Treatment·Theresa B MoyersWilliam R Miller
Jun 11, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Carl J PossidenteWalter J McClain
Jul 21, 2006·The Cochrane Database of Systematic Reviews·S RuedaR H Glazier
Jan 30, 2007·International Journal of Nursing Studies·David A BrodieDavid G Shaw
Oct 3, 2008·Journal of Managed Care Pharmacy : JMCP·Susan W Butterworth
Jan 7, 2009·Health Affairs·Katie ColemanEdward H Wagner
May 21, 2009·Health Affairs·Donald M Berwick

❮ Previous
Next ❯

Citations

Dec 12, 2012·Family Practice·Janneke NoordmanSandra van Dulmen
Dec 12, 2012·Journal of Clinical Medicine Research·Janneke NoordmanSandra van Dulmen
Sep 29, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Margot GeertsNicolaas C Schaper
Dec 24, 2015·The Journal of Behavioral Health Services & Research·Vera-Christina MertensMariëlle E J B Goossens
May 13, 2015·Contemporary Clinical Trials·Judith G M JelsmaLars Forsberg
Jan 1, 2014·Journal of Clinical Nursing·Ann-Sofi ÖstlundMarja-Leena Kristofferzon
Jul 25, 2015·BMC Family Practice·Ann-Sofi ÖstlundBarbro Wadensten
May 17, 2011·Patient Education and Counseling·Kathryn I Pollak
May 9, 2016·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Kathryn I PollakTerrill D Bravender
Mar 26, 2014·Addiction·Craig S SchwalbeAllen Zweben
Sep 28, 2017·British Journal of Health Psychology·Heleen WestlandMarieke J Schuurmans
May 11, 2021·Health Psychology Review·Tracey KaczmarekJaap J Van Netten

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.